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Abstract
Introduction:  Obstructive  sleep  apnea  has  been  associated  with  higher  cancer  incidence  and
mortality.  Increased  melanoma  aggressivity  was  reported  in  obstructive  sleep  apnea  patients.
Mice exposed  to  intermittent  hypoxia  (IH)  mimicking  sleep  apnea  show  enhanced  melanoma
growth. Markers  of  melanoma  progression  have  not  been  investigated  in  this  model.
Objective:  The  present  study  examined  whether  IH  affects  markers  of  melanoma  tumor  pro-
gression.
Methods: Mice  were  exposed  to  isocapnic  IH  to  a  nadir  of  8%  oxygen  fraction  for  14  days.
One million  B16F10  melanoma  cells  were  injected  subcutaneously.  Immunohistochemistry  stain-
ing for  Ki-67,  PCNA,  S100-beta,  HMB-45,  Melan-A,  TGF-beta,  Caspase-1,  and  HIF-1alpha  were
quantiﬁed using  Photoshop.
Results:  Percentage  of  positive  area  stained  was  higher  in  IH  than  sham  IH  group  for  Caspase-1,
Ki-67, PCNA,  and  Melan-A.  The  greater  expression  of  several  markers  of  tumor  aggressive-
ness, including  markers  of  ribosomal  RNA  transcription  (Ki-67)  and  of  DNA  synthesis  (PCNA),  in
mice exposed  to  isocapnic  IH  than  in  controls  provide  molecular  evidence  for  a  apnea--cancer
relationship.
Conclusions:  These  ﬁndings  have  potential  repercussions  in  the  understanding  of  differences  in
clinical course  of  tumors  in  obstructive  sleep  apnea  patients.  Further  investigation  is  necessary
to conﬁrm  mechanisms  of  these  descriptive  results.
© 2015  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
Inc-nd/4.0/).∗ Corresponding author.
E-mail address: carolmontanari@gmail.com (C.C. Montanari).
E
(
w
http://dx.doi.org/10.1016/j.rppnen.2015.11.004
2173-5115/© 2015 Sociedade Portuguesa de Pneumologia. Published by 
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)ntroductionpidemiological  data  connects  obstructive  sleep  apnea
OSA)  with  cancer  mortality  and  incidence1--4 as  well  as
ith  melanoma  aggressivity.5 Intermittent  hypoxia  (IH),  a
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eature  of  OSA,6 is  used  as  a  model  to  investigate  outcomes
f  this  disease.7 Exposure  to  6  h  of  one  episode  of  hypoxia
er  minute  to  an  oxygen  nadir  of  5%  augments  melanoma
rowth8 and  metastasis  in  mice.9 In  this  model,  both  obe-
ity  and  IH  affect  melanoma  growth,  with  non-addictive
ffect.10,11
Several  proteins  are  altered  speciﬁcally  in  melanoma
nd  have  prognostic  value.  S100  calcium  binding  protein  B
S100-)  is  a  prognostic  marker  for  melanoma  stage,  disease
ecurrence,  and  low  overall  patient  survival12 Augmented
xpression  of  proliferation  marker  Ki-67  indicates  increased
ibosomal  RNA  transcription.13 Greater  expression  of  pro-
iferating  cell  nuclear  antigen  (PCNA)  in  the  cell  nucleus
ndicates  greater  DNA  synthesis.  The  presence  of  hypoxia-
nducible  factor  1-alpha  (HIF-1) suggests  the  exposure  of
he  cell  to  hypoxia.  The  protein  transforming  growth  fac-
or  beta  (TGF-) controls  proliferation,  differentiation,  and
ther  functions  in  cells.  Caspase-1  induces  cell  apoptosis  and
s  a  marker  of  malignancy.  Melan-A  and  human  melanoma
lack  45  (HMB-45)  are  antigens  markers  of  melanocytes,
sed  to  identify  a  tumor  as  a  melanoma.14
The  various  stages  of  tumor  formation  and  progres-
ion  can  be  regulated  by  hypoxia.15--18 Knowledge,  however,
ocusing  speciﬁcally  on  IH  simulating  OSA  and  its  molecular
ffects  in  melanoma  aggressiveness  is  incipient.
The  aim  of  the  present  study  is  to  test  the  hypothesis  that
n  animal  model  simulating  OSA  intensiﬁes  the  expression
f  aggressiveness  markers.  In  this  investigation,  mice  were
xposed  to  14  days  of  isocapnic  IH,  similar  to  severe  OSA.
ethods
nimals
welve  2-month-old  male  C57BL/6  mice,  weighing  between
5  and  30  g  at  the  beginning  of  the  study,  were  used  in  the
tudy;  six  exposed  to  isocapnic  IH  and  six  controls  exposed
o  sham  IH.  Except  for  the  gas  mixture,  both  groups  of
elanoma-injected  mice  were  subjected  to  the  same  proto-
ol.  The  animals  were  housed  under  temperatures  ranging
etween  22.5  and  24.5 ◦C  with  a  12:12-h  light-dark  cycle
nd  received  ad  libitum  standard  mice  chow  and  water.  The
rotocol  was  approved  by  the  Committee  on  the  Ethics  of
nimal  Experiments  of  the  Hospital  de  Clínicas  de  Porto
legre  (Permit  Number:  09-483)  and  conducted  in  accor-
ance  with  the  Guide  for  the  Care  and  Use  of  Laboratory
nimals.19
socapnic  intermittent  hypoxia
he  isocapnic  IH  system  was  described  in  detail  before.20--22
n  brief,  for  14  days,  8  h  per  day,  from  9  AM  to  5  PM,  in  the
ights  on  period,  the  animals  were  kept  in  the  hypoxia  sys-
em.  During  30  s a  mixture  with  92%  nitrogen  and  8%  CO2 was
eleased  into  the  hypoxia  chamber.  A  nadir  of  inspired  oxy-
en  fraction  of  7  ±  1%  and  a  peak  of  inspired  carbon  dioxide
f  6  ±  1%  were  reached  as  conﬁrmed  by  sensors  inside  the
age.  Next,  room  air  was  insufﬂated  during  30  s  to  restore
ormoxia.  The  exposure  to  isocapnic  IH  started  on  the  same
ay  as  the  injection  of  melanoma  cells.
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elanoma  cells
o  induce  melanoma  in  the  mice,  1  ×  106 B16F10  cells  (ATCC-
RL-6475;  American  Type  Culture  Collection,  Manassas,  VA,
SA)  were  used.  The  cells  were  suspended  in  150  l  of  phos-
hate  buffered  saline  and  injected  subcutaneously  in  the
eft  hind  limb  of  each  mouse.
On  the  last  day  of  the  experiment,  each  mouse  was
emoved  from  the  IH  system  to  be  immediately  anes-
hetized  with  ketamine  (100  mg/kg)  and  xylazine  (10  mg/kg)
ntraperitoneally.  The  animals  were  not  weighed  at  this
oment.  After  deep  anesthesia  was  conﬁrmed,  the  tumors
ere  excised  and  ﬁxed.  After  tumor  excision  the  mice  were
uthanized  in  a  CO2 chamber  and  the  organs  were  macro-
copically  examined  for  metastasis.
ematoxylin-eosin  and  immunohistochemistry
he  parafﬁn  blocks  of  the  tumor  were  sectioned  in  5 m
lices.  Sections  were  mounted  on  glass  slides,  stained  with
ematoxylin-eosin,  and  the  tumor  diameters  measured.  The
mmunohistochemical  staining  was  processed  using  primary
onoclonal  mouse  antibodies  against:  (1)  HIF-1 (1:200
ilution;  sc-53546),  (2)  TGF- (1:200  dilution;  sc-398),  (3)
100-  (1:400  dilution;  sc-28533),  (4)  Melan-A  (1:200  dilu-
ion;  sc-20032),  (5)  Caspase-1  (1:200  dilution;  sc-56036)
all  Santa  Cruz  Biotechnology  Inc.,  Santa  Cruz,  CA,  USA),
6)  HMB-45  (1:100  dilution;  HMB-45;  Dako,  Carpinteria,  CA,
SA),  (7)  Ki-67  (1:50  dilution;  SP6;  Cell  Marque,  Rocklin  CA,
SA),  and  (8)  PCNA  (1:200  dilution;  307901;  BioLegend,  San
iego,  CA,  USA).
The  secondary  antibody  was  PicTureTM-MAX  Polymer
etection  kit,  87-8983  (Invitrogen,  Camarillo,  CA,  USA),
hich  reacts  with  mouse  antibodies.  The  color  was  devel-
ped  with  a  DAB  Chromogen.  Sections  were  counterstained
ith  hematoxylin-Harris  and  rinsed  with  ammoniacal  water
o  obtain  a light  blue  color.
Three  pictures  of  each  slide  at  400× were  quantiﬁed  for
mmunohistochemistry  staining  by  Adobe  PhotoshopTM.  Two
ifferent  readers,  blind  to  the  exposure  groups  performed
he  staining  analyses.  The  readings  were  averaged.  When
wo  measurements  disagreed  by  more  than  5%,  readings
rom  a  third  observer  were  utilized  instead  of  the  one  with
reater  disparity  among  the  three.23
tatistical  analysis
tatistical  analysis  was  performed  using  SPSS  (SPSS,  Chicago,
L).  Medians  and  quartiles  [25th--75th]  were  utilized  to
xpress  grouped  data.  Mann--Whitney  test  was  used  to  com-
are  measurements  of  percentage  of  stained  area.  Results
ere  considered  signiﬁcant  when  the  probability  of  alpha
rror  was  <0.05.
esultshe  median  tumor  diameter  in  the  hypoxia  group,  was  9  mm
interquartile  range  (IQR):  6--11  mm],  50%  larger  than  in  the
ontrol  group,  6  mm  [IQR:  4--13  mm].  The  difference,  how-
ver,  did  not  reach  signiﬁcance  (P  =  0.6).  No  macroscopic
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reproduction of  the  immunohistochemistry  slides  in  control  (sha
evidence  of  metastases  was  observed  in  brain  and  lungs  of
mice.
Caspase-1,  Ki-67,  and  PCNA  were  signiﬁcantly  different
between  hypoxia  and  control  groups  in  terms  of  the  per-
centage  of  positive  area  of  the  markers  (Fig.  1).  HIF-1 and
Melan-A  had  signiﬁcant  differences  between  hypoxia  and
control  groups  only  in  percentage  of  positive  area;  HMB-45,
and  TGF- had  not  signiﬁcant  differences  between  hypoxia
and  control  groups;  S100- had  similar  percentage  of  posi-
tive  area  in  the  hypoxia  and  control  groups  (Fig.  2).
Discussion
Our  results  indicate  that  an  isocapnic  IH  model,  mimicking
OSA,  increases  the  aggressiveness  of  melanoma.  The  tumors
from  the  hypoxia  group  can  be  considered  of  higher  grade
than  the  ones  from  the  control  group.  This  is  the  ﬁrst  report
of  increased  expression  of  Ki-67  and  PCNA  by  IH.  Besides
supporting  previous  ﬁndings,7--10 the  present  results  suggest
a  malignancy-enhancing  effect  of  OSA.
The  PCNA  is  a  protein  essential  both  for  DNA  replication
and  repair  used  as  a  proliferation  marker.  It  participates  as
a  DNA  polymerase  accessory  in  the  synthesis  of  DNA  dur-
ing  the  S  phase  and  interacts  with  cellular  proteins  involved
in  the  regulation  of  cell  cycle.24,25 Enhanced  expression  of
PCNA  is  associated  with  increases  in  metastasis  and  with
lower  survival  rates.  In  advanced  gastric  cancer,26 prolifer-
ation  indices,  i.e.,  the  percentage  of  cells  dividing,  above
50%  as  marked  by  either  PCNA  or  Ki-67  are  associated  with
a  three  times  higher  mortality  at  40  months.
t
d
I,  and  PCNA.  Box-plots  of:  (A)  percentage  of  positive  area;  (B)
;  SIH)  and  intermittent  hypoxia  (IH)  groups.
Ki-67,  a  nuclear  and  nucleolar  protein  linked  to  the  pro-
iferation  of  somatic  cells,  is  expressed  in  phases  G1,  S,  G2,
nd  mitosis,  but  not  in  the  G0  phase.  This  makes  Ki-67  one  of
he  most  often  utilized  markers  to  determine  the  fraction  of
roliferating  cells  in  various  tumors.  The  expression  of  Ki-67
n  melanocytic  lesions  has  a  role  as  diagnostic  biomarker,  and
 marker  of  poor  prognosis.27 Anorectal  melanoma  patients
ith  40%  or  more  of  the  nuclei  positive  for  Ki-67  are  all
eceased  in  40  months,  while  less  than  40%  of  the  patients
ith  Ki-67  scores  below  this  threshold  died  in  the  same
eriod.  No  patient  with  more  than  80%  of  PCNA  positive
uclei  survived  more  than  30  months  while  about  60%  of
he  patients  with  lower  PCNA  scores  were  alive  at  this  time
oint.28
In  the  present  study,  the  tumor  size  of  the  hypoxia  group,
espite  being  50%  larger  than  that  of  the  control  group,
s  non-signiﬁcantly  different.  Previous  reports7--10 utilized
onger  duration  of  exposure  and  IH  with  a  lower  inspired
xygen  nadir  than  the  present  experiment.  Since  the  tumor
rowth  is  exponential,  it  might  have  been  possible  to  reach  a
igniﬁcant  difference  in  size  by  allowing  a  few  more  days  of
xposure.  Although  all  animals  were  injected  with  the  same
umber  of  cells,  each  tumor  may  derive  from  implants  of
ifferent  sizes,  increasing  the  variability  of  this  measure-
ent.  Additionally,  unexpected  cell  lysis  during  injection
ould  have  triggered  inﬂammatory/immune  responses  that
ould  alter  tumor  growth,  increasing  the  unevenness  of
umor  size.
No  metastases  were  observed  in  our  study  after  14
ays,  agreeing  with  the  literature  on  this  subject.  Under
H,  Almendros  et  al.9 have  observed  spontaneous  lung
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Protection  of  human  and  animal  subjects.  The  authorsigure  2  Percentage  of  positive  area  of  HMB-45,  Melan-A,  TG
eproduction  of  the  immunohistochemistry  slides  in  control  (sh
etastases  after  30  days  of  the  tumor  cells  injection.  In  their
tudy,  13  out  of  18  mice  under  IH  survived  until  day  30.  The
eterinarian  in  charge  of  our  animals  considered  that  pro-
onging  the  study  beyond  14  days  would  cause  unnecessary
uffering  to  the  mice.  The  model  used  by  them,  with  tumor
ells  being  injected  in  a  tail  vein  proved  to  be  a  suitable  way
o  obtain  metastasis  in  21  days,  before  tumor  growth  causes
eath  and  distress  to  the  experimental  animals.
Melanoma  showed  to  be  an  appropriate  cancer  model  to
est  the  hypothesis  of  hypoxia  affecting  cancer  aggressive-
ess.  More  than  430  hypoxia-responsive  genes  have  been
dentiﬁed  in  the  B16F10  murine  melanoma  cell  line,  in
itro.29
The  ﬁnding  of  HIF-1 expression  being  lower  under  IH
s  an  unexpected  ﬁnding.  In  presence  of  hypoxia,  ubi-
uitination  of  HIF-1 is  reduced,  allowing  the  protein  to
ccumulate.30 IH,  however,  occurring  during  8  h  per  day,  is  a
uch  more  complex  phenomenon  than  constant  hypoxia.  In
pnea-like  IH  the  tissues  undergo  hypoxic  episodes  of  short
uration.  In  our  model,  hypoxia  totals  4  h,  i.e.,  480  cycles
ith  30  s  of  declining  PIO2.  The  rest  of  the  day,  for  around
6  h  per  day  out  of  the  hypoxic  chamber  plus  4  h  of  room  air
reathing  at  each  30-s  recovery  period,  the  cells  are  in  their
sual  normoxic  conditions.  This  permits  full  recovery  of  HIF-
  levels  from  the  regulating  processes  that  would  increase
ts  expression.  A  model  of  IH  alternating  1  h  of  1%  oxygen
ith  30  min  of  20%  oxygen  promotes  angioneogenesis.16 It
s  possible  to  speculate  that  the  IH  promoted  formation
f  extra  blood  vessels,  enhancing  oxygen  supply  to  tumor
ells.
d
w
c
M and  S100-.  Box-plots  of:  (A)  percentage  of  positive  area;  (B)
;  SIH)  and  intermittent  hypoxia  (IH)  groups.
Greater  positive  area  of  Melan-A  staining  in  the  IH  group
ay  indicate  a  greater  expression  of  melanocytic  proteins.31
his  is  indicative  of  melanocytic  proliferation  but  not  nec-
ssarily  of  greater  malignancy.
One  limitation  of  the  present  study  is  the  lack  of  power
o  accept  the  negative  results.  At  the  time  the  experiments
ere  carried  out  no  evidence  of  a  cancer-IH  relation  existed.
he  ethics  committee  insisted  on  a  small  number  of  animals
n  this  ﬁrst  exploratory  phase.  The  positive  ﬁndings,  how-
ver,  based  in  immunohistochemistry  are  solid  enough  to
riginate  future  research.  An  ideal  project  should  include
enetic  and  pharmacological  interventions  that  would  allow
nderstanding  of  the  mechanisms  activated  by  the  IH.  The
nvestigation  of  mechanisms,  however,  is  outside  the  scope
f  the  search  for  melanoma  markers  that  might  be  affected
n  OSA.
The  enhanced  expression  of  markers  of  tumor  aggres-
iveness  under  IH  may  suggest  a  molecular  basis  for  the
pnea-cancer  relationship.  Additional  investigation  of  the
olecular  mechanisms  triggered  by  IH  that  are  relevant  to
alignancy  is  warranted  by  these  results.
thical responsibilitieseclare  that  the  procedures  followed  were  in  accordance
ith  the  regulations  of  the  relevant  clinical  research  ethics
ommittee  and  with  those  of  the  Code  of  Ethics  of  the  World
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